<SEC-DOCUMENT>0001213900-25-014390.txt : 20250214
<SEC-HEADER>0001213900-25-014390.hdr.sgml : 20250214
<ACCEPTANCE-DATETIME>20250214170004
ACCESSION NUMBER:		0001213900-25-014390
CONFORMED SUBMISSION TYPE:	SCHEDULE 13G
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250214
DATE AS OF CHANGE:		20250214

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Health In Tech, Inc.
		CENTRAL INDEX KEY:			0002019505
		STANDARD INDUSTRIAL CLASSIFICATION:	INSURANCE AGENTS BROKERS & SERVICES [6411]
		ORGANIZATION NAME:           	02 Finance
		IRS NUMBER:				000000000

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-94862
		FILM NUMBER:		25630515

	BUSINESS ADDRESS:	
		STREET 1:		701 S. COLORADO AVE
		STREET 2:		SUITE 1
		CITY:			STUART
		STATE:			FL
		ZIP:			34994
		BUSINESS PHONE:		888-373-0333

	MAIL ADDRESS:	
		STREET 1:		701 S. COLORADO AVE
		STREET 2:		SUITE 1
		CITY:			STUART
		STATE:			FL
		ZIP:			34994

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Johnson Tim Donald
		CENTRAL INDEX KEY:			0001993657
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G

	MAIL ADDRESS:	
		STREET 1:		701 S. COLORADO AVE
		STREET 2:		SUITE 1
		CITY:			STUART
		STATE:			FL
		ZIP:			34994
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13G
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13G</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: Johnson Tim Donald -->
          <cik>0001993657</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>


    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <securitiesClassTitle>Class A Common Stock, $0.001 par value per share</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>12/31/2024</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0002019505</issuerCik>
        <issuerName>Health In Tech, Inc.</issuerName>
        <issuerCusip>42217D102</issuerCusip>
        <issuerPrincipalExecutiveOfficeAddress>
          <com:street1>701 S. Colorado Ave,</com:street1>
          <com:street2>Suite 1,</com:street2>
          <com:city>Stuart</com:city>
          <com:stateOrCountry>FL</com:stateOrCountry>
          <com:zipCode>34994</com:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(d)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Tim Johnson</reportingPersonName>
      <citizenshipOrOrganization>X1</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>32170448.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>32170448.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>32170448.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>60.4</classPercent>
      <typeOfReportingPerson>IN</typeOfReportingPerson>
      <comments>(1) Represents (i) 22,315,651 shares of Class A Common Stock, (ii) 82,500 restricted shares of Class A Common Stock granted pursuant to the Health in Tech Equity Incentive Plan, which vest six months after the closing of the issuer's initial public offering, or June 24, 2025, subject to the reporting person's continued service with the issuer through such vesting date, (iii) 37,590 restricted shares of Class A Common Stock granted pursuant to the Health in Tech Equity Incentive Plan, which vest in equal quarterly installments over two years following the issuer's initial public offering, subject to the reporting person's continued service with the issuer through each vesting date, (iv) 9,000,000 shares of Class B Common Stock, with each share convertible at any time into one share of Class A Common Stock for no additional consideration, (v) 495,000 options to purchase shares of Class A Common Stock granted pursuant to the Health in Tech Equity Incentive Plan, which vest six months after the closing of the issuer's initial public offering, or June 24, 2025, subject to the reporting person's continued service with the issuer through such vesting date, (vi) 170,115 options to purchase shares of Class A Common Stock granted pursuant to the Health in Tech Equity Incentive Plan, which vest over three years, with one-third of the options vested upon the issuer's initial public offering on December 24, 2024 and the remaining two-thirds vesting in equal quarterly installments over the remaining two years, subject to the reporting person's continued service with the issuer through each vesting date, and (vii) 69,592 options to purchase shares of Class A Common Stock granted pursuant to the Health in Tech Equity Incentive Plan, which vested upon the issuer's initial public offering on December 24, 2024. (2) This percentage is based on 42,369,358 shares of Class A Common Stock outstanding, 1,145,182 shares of restricted stock outstanding, and an aggregate of 9,734,707 shares, comprised of (i) 9,000,000 shares of Class B Common Stock, and (ii) an aggregate of 734,707 options to purchase shares of Class A Common Stock granted pursuant to the Health in Tech Equity Incentive Plan, which are deemed to be outstanding and beneficially owned by the reporting person for the purpose of computing the percentage ownership of that person but are not treated as outstanding for the purpose of computing the percentage ownership of any other person. The number of shares outstanding is based on the Issuer's Prospectus filed pursuant to Rule 424(b)(4) by the issuer with the Securities and Exchange Commission on December 23, 2024.</comments>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>Health In Tech, Inc.</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>701 S. Colorado Ave, Suite 1, Stuart, FL 34994</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>Tim Johnson</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>s/o Health In Tech, Inc.
701 S. Colorado Ave, Suite 1
Stuart, FL 34994</principalBusinessOfficeOrResidenceAddress>
        <citizenship>United States</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>Y</notApplicableFlag>
      </item3>
      <item4>
        <amountBeneficiallyOwned>32,170,448. Represents (i) 22,315,651 shares of Class A Common Stock, (ii) 82,500 restricted shares of Class A Common Stock granted pursuant to the Health in Tech Equity Incentive Plan, which vest six months after the closing of the issuer's initial public offering, or June 24, 2025, subject to the reporting person's continued service with the issuer through such vesting date, (iii) 37,590 restricted shares of Class A Common Stock granted pursuant to the Health in Tech Equity Incentive Plan, which vest in equal quarterly installments over two years following the issuer's initial public offering, subject to the reporting person's continued service with the issuer through each vesting date, (iv) 9,000,000 shares of Class B Common Stock, with each share convertible at any time into one share of Class A Common Stock for no additional consideration, (v) 495,000 options to purchase shares of Class A Common Stock granted pursuant to the Health in Tech Equity Incentive Plan, which vest six months after the closing of the issuer's initial public offering, or June 24, 2025, subject to the reporting person's continued service with the issuer through such vesting date, (vi) 170,115 options to purchase shares of Class A Common Stock granted pursuant to the Health in Tech Equity Incentive Plan, which vest over three years, with one-third of the options vested upon the issuer's initial public offering on December 24, 2024 and the remaining two-thirds vesting in equal quarterly installments over the remaining two years, subject to the reporting person's continued service with the issuer through each vesting date, and (vii) 69,592 options to purchase shares of Class A Common Stock granted pursuant to the Health in Tech Equity Incentive Plan, which vested upon the issuer's initial public offering on December 24, 2024.</amountBeneficiallyOwned>
        <classPercent>60.4%. This percentage is based on 42,369,358 shares of Class A Common Stock outstanding, 1,145,182 shares of restricted stock outstanding and an aggregate of 9,734,707 shares, comprised of (i) 9,000,000 shares of Class B Common Stock, and (ii) an aggregate of 734,707 options to purchase shares of Class A Common Stock granted pursuant to the Health in Tech Equity Incentive Plan, which are deemed to be outstanding and beneficially owned by the reporting person for the purpose of computing the percentage ownership of that person but are not treated as outstanding for the purpose of computing the percentage ownership of any other person. The number of shares outstanding is based on the Issuer's Prospectus filed pursuant to Rule 424(b)(4) by the issuer with the Securities and Exchange Commission on December 23, 2024.</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>32,170,448. Represents (i) 22,315,651 shares of Class A Common Stock, (ii) 82,500 restricted shares of Class A Common Stock granted pursuant to the Health in Tech Equity Incentive Plan, which vest six months after the closing of the issuer's initial public offering, or June 24, 2025, subject to the reporting person's continued service with the issuer through such vesting date, (iii) 37,590 restricted shares of Class A Common Stock granted pursuant to the Health in Tech Equity Incentive Plan, which vest in equal quarterly installments over two years following the issuer's initial public offering, subject to the reporting person's continued service with the issuer through each vesting date, (iv) 9,000,000 shares of Class B Common Stock, with each share convertible at any time into one share of Class A Common Stock for no additional consideration, (v) 495,000 options to purchase shares of Class A Common Stock granted pursuant to the Health in Tech Equity Incentive Plan, which vest six months after the closing of the issuer's initial public offering, or June 24, 2025, subject to the reporting person's continued service with the issuer through such vesting date, (vi) 170,115 options to purchase shares of Class A Common Stock granted pursuant to the Health in Tech Equity Incentive Plan, which vest over three years, with one-third of the options vested upon the issuer's initial public offering on December 24, 2024 and the remaining two-thirds vesting in equal quarterly installments over the remaining two years, subject to the reporting person's continued service with the issuer through each vesting date, and (vii) 69,592 options to purchase shares of Class A Common Stock granted pursuant to the Health in Tech Equity Incentive Plan, which vested upon the issuer's initial public offering on December 24, 2024.</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>0</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>32,170,448. Represents (i) 22,315,651 shares of Class A Common Stock, (ii) 82,500 restricted shares of Class A Common Stock granted pursuant to the Health in Tech Equity Incentive Plan, which vest six months after the closing of the issuer's initial public offering, or June 24, 2025, subject to the reporting person's continued service with the issuer through such vesting date, (iii) 37,590 restricted shares of Class A Common Stock granted pursuant to the Health in Tech Equity Incentive Plan, which vestin equal quarterly installments over two years following the issuer's initial public offering, subject to the reporting person's continued service with the issuer through each vesting date, (iv) 9,000,000 shares of Class B Common Stock, with each share convertible at any time into one share of Class A Common Stock for no additional consideration, (v) 495,000 options to purchase shares of Class A Common Stock granted pursuant to the Health in Tech Equity Incentive Plan, which vest six months after the closing of the issuer's initial public offering, or June 24, 2025, subject to the reporting person's continued service with the issuer through such vesting date, (vi) 170,115 options to purchase shares of Class A Common Stock granted pursuant to the Health in Tech Equity Incentive Plan, which vest over three years, with one-third of the options vested upon the issuer's initial public offering on December 24, 2024 and the remaining two-thirds vesting in equal quarterly installments over the remaining two years, subject to the reporting person's continued service with the issuer through each vesting date, and (vii) 69,592 options to purchase shares of Class A Common Stock granted pursuant to the Health in Tech Equity Incentive Plan, which vested upon the issuer's initial public offering on December 24, 2024.</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>0</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>Y</notApplicableFlag>
      </item5>
      <item6>
        <notApplicableFlag>Y</notApplicableFlag>
      </item6>
      <item7>
        <notApplicableFlag>Y</notApplicableFlag>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>Y</notApplicableFlag>
      </item10>
    </items>
    <signatureInformation>
      <reportingPersonName>Tim Johnson</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Tim Johnson</signature>
        <title>Tim Johnson</title>
        <date>02/14/2025</date>
      </signatureDetails>
    </signatureInformation>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
